Ars Investment Partners, LLC Moderna, Inc. Transaction History

Ars Investment Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $3.01 Million - $4.53 Million	-43,363 Reduced 61.73%	26,887 $2.67 Million
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $135,552 - $178,013	-1,406 Reduced 1.96%	70,250 $7.26 Million
Q2 2023 Jul 11, 2023	SELL	$118.5 - $160.53 $489,049 - $662,507	-4,127 Reduced 5.45%	71,656 $8.71 Million
Q1 2023 Apr 05, 2023	BUY	$135.66 - $197.02 $72,849 - $105,799	537 Added 0.71%	75,783 $11.6 Million
Q4 2022 Jan 25, 2023	BUY	$118.38 - $210.04 $8.49 Million - $15.1 Million	71,736 Added 2043.76%	75,246 $0
Q3 2022 Oct 07, 2022	BUY	$118.07 - $194.18 $414,425 - $681,571	3,510 New	3,510 $415,000
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $407,241 - $693,705	-3,730 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$65.74 - $169.86 $34,842 - $90,025	530 Added 16.56%	3,730 $390,000
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $173,888 - $303,520	3,200 New	3,200 $226,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ars Investment Partners, LLC with notifications on news.